查看購物車
  • English
  • Japanese
  • Korean
全球供應商中立歸檔 (VNA) 和 PACS 市場（至 2031 年）：按產品類型（部門、多部門、多地點）、模式（CT、MRI、X 光、超音波、乳房X光攝影）、應用（心臟科、腫瘤科、神經科）和最終用戶（醫院、門診手術中心、診斷中心）分類
市場調查報告書
商品編碼
2055587

全球供應商中立歸檔 (VNA) 和 PACS 市場（至 2031 年）：按產品類型（部門、多部門、多地點）、模式（CT、MRI、X 光、超音波、乳房X光攝影）、應用（心臟科、腫瘤科、神經科）和最終用戶（醫院、門診手術中心、診斷中心）分類

Vendor Neutral Archive (VNA) & PACS Market by Product Type (Department, Multi-department, Multi-site), Modality (CT, MRI, X-ray, Ultrasound, Mammo), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diagnostic Center) - Global Forecast to 2031
出版日期: | 出版商: MarketsandMarkets | 英文 326 Pages | 訂單完成後即時交付

價格

預計廠商中立歸檔（VNA）和 PACS 市場將從 2026 年的 56 億美元成長到 2031 年的 85.7 億美元，複合年成長率為 8.9%。

隨著醫療服務模式的演變，VNA 和 PACS 市場需求日益成長。醫療服務提供者需要影像診斷平台來支援跨醫院、診所和診斷機構的醫療協調。以數據為中心的醫療模式的採用正在推動對影像記錄的需求成長。這使得臨床醫生能夠訪問患者病歷，從而為診斷和治療計劃提供依據。

調查範圍
調查期 2026-2031
基準年 2025
預測期 2026-2031
單元 金額（美元）
部分 產品類型、模式、部署方式、供應商類型、應用程式、最終用戶
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

此外，門診影像中心對雲端的PACS和VNA系統的需求日益成長，以支援其影像診斷流程。同時，供應商擴大採用SaaS（軟體即服務）經營模式，這正在影響著尋求更靈活選擇和更低總體擁有成本（TCO）的醫療服務提供者的策略。近期產業內的併購活動，例如GE醫療（美國）於2026年3月收購Intelerad醫療系統公司（加拿大），進一步推動了這項需求。

廠商中立歸檔 (VNA) 和 PACS 市場-IMG1

「按產品類型分類，預計到 2025 年，窄巷道機床 (VNA) 將佔據最大的市場佔有率。”

這是因為虛擬網路存取（VNA）使醫療機構能夠集中管理影像數據，並透過不同系統間的互通性確保IT基礎設施的永續性。借助VNA，醫療服務提供者可以將資料與其自身的PACS系統分離，從而實現輕鬆的資訊交流，避免系統依賴性問題。如同2023年醫療資訊與管理系統協會（HIMSS）會議上所指出的，醫療機構正在轉向以互通性和廠商中立性基礎設施為特徵的企業級影像解決方案，以促進更優質的患者照護並改善資訊取得。同樣，根據歐洲放射學會的說法，長期影像儲存和公司間資料交換在當今放射學領域已成為至關重要的環節。近期行業趨勢表明，美國Hyland Software公司正在開發一款基於雲端的VNA解決方案，以滿足大型企業在2025年的需求。

“按供應商類型分類，預計第三方供應商板塊在預測期內將經歷最快的成長。”

預計在預測期內，第三方供應商市場將呈現最高的成長率，這主要得益於不同醫療IT環境之間互通性需求的不斷成長。第三方供應商致力於提供解決方案，確保PACS、VNA、EHR以及其他各種臨床軟體應用程式之間的互通性，使醫療機構能夠在保持現有基礎設施的同時整合所有數據。正如Radsource在2025年1月進行的一項調查所指出的，PACS互通性透過允許醫療機構與其他醫療系統交換數據，有助於簡化工作流程並改善整體患者照護。近期，BridgeHead Software Ltd.（英國）和PaxeraHealth Corp.（美國）對互通資料管理解決方案的改進，凸顯了PACS互通性的重要性。

“預計亞太地區在預測期內將錄得最高的成長率。”

亞太地區的VNA和PACS市場正經歷強勁成長，這主要得益於醫療基礎設施投入的增加、醫院數位化進程的加速以及大量患者對診斷影像日益成長的需求。該地區各國政府正積極推動國家級數位健康戰略，以改善數據交換和存取。世界衛生組織（世衛組織）2021年的報告指出，亞太地區各國正在加速採用數位健康技術，以最佳化醫療系統的效率和服務交付。此外，連鎖醫院的發展和電子健康記錄的日益普及也推動了對綜合影像資料管理系統的需求。例如，富士膠片控股株式會社（日本）計劃在2025年將其企業影像解決方案擴展到亞太地區，佳能醫療系統株式會社（日本）也計劃在2025年加強其影像資訊學相關產品和服務。

本報告檢視了全球供應商中立歸檔（VNA）和 PACS 市場，提供了市場概述、影響市場成長的各種因素分析、技術和專利趨勢、法律制度、案例研究、歷史和預測市場規模、按細分市場、地區/主要國家/地區進行的詳細分析、競爭格局以及主要公司的概況。

目錄

第1章：引言

第2章執行摘要

第3章重要考察

第4章 市場概覽

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務
  • 未滿足的需求和閒置頻段
  • 與相關市場和不同產業相關的跨領域機遇
  • 一級/二級/三級公司的策略性舉措

第5章 產業趨勢

  • 波特五力分析
  • 總體經濟指標
    • GDP趨勢與預測
    • 全球醫療保健IT產業趨勢
  • 價值鏈分析
  • 生態系測繪
  • 價格分析
  • 2026-2027 年主要會議和活動
  • 影響客戶業務的趨勢/顛覆性因素
  • 投資和資金籌措場景
  • 案例研究分析
  • 2025年美國關稅影響概述
  • 對國家和地區的影響
  • 對終端用戶產業的影響
  • 結論

第6章：技術進步、人工智慧的影響、專利、創新與未來應用

  • 主要新興技術
    • DICOM (Digital Imaging and Communications in Medicine)
    • 企業影像解決方案
    • 基於雲端的儲存和服務
  • 互補技術
    • 影像交換網路
    • 數據分析和商業智慧
  • 鄰近技術
    • 交換醫療資訊（HIE）
  • 專利分析
  • 未來應用

第7章 監理情勢

  • 當地法規和合規性

第8章：顧客趨勢與購買行為

  • 決策流程
  • 採購相關利益者和採購評估標準
  • 實施障礙和內部挑戰
  • 各個終端用戶產業尚未滿足的需求
  • 市場盈利

第9章 廠商中立歸檔系統 (VNA) 與 PACS 市場：依產品類型分類

  • VNA
    • 部門 VNA
    • 多部門VNA
    • 多站點VNA
  • PACS
    • 部門PACS
    • 支援多部門的PACS系統
    • 多站點PACS

第10章 廠商中立歸檔（VNA）與 PACS 市場：依模態分類

  • CT
  • 乳房X光檢查
  • 超音波
  • 磁振造影（MRI）
  • X光
  • PET

第11章 廠商中立歸檔（VNA）與 PACS 市場：依部署類型分類

  • 本地部署模式
  • 雲端基礎模式
  • 混合模式

第12章 廠商中立歸檔（VNA）和 PACS 市場：依廠商類型分類

  • 獨立供應商
  • 第三方供應商

第13章 廠商中立歸檔（VNA）和 PACS 市場：依應用分類

  • 心臟病
  • 整形外科
  • 瘤
  • 神經
  • 婦產科
  • 其他

第14章 廠商中立歸檔（VNA）和 PACS 市場：依最終用戶分類

  • 醫院和診所
  • 診斷中心
  • 門診手術中心
  • 其他

第15章 廠商中立歸檔系統 (VNA) 與 PACS 市場：依地區分類

  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太地區宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 其他

第16章 競爭格局

  • 概述
  • 主要公司/主要企業的策略
  • 所得分配分析
  • 市佔率分析
  • 企業估值矩陣：主要公司
  • 公司估值矩陣：新創企業/中小企業
  • 企業估值和財務指標
  • 品牌/軟體對比
  • 競爭格局

第17章：公司簡介

  • 大公司
    • AGFA-GEVAERT GROUP
    • FUJIFILM HOLDINGS CORPORATION
    • SECTRA AB
    • GE HEALTHCARE
    • MERATIVE
    • KONINKLIJKE PHILIPS NV
    • CANON MEDICAL SYSTEMS CORPORATION
    • PAXERAHEALTH
    • NOVARAD CORPORATION
    • HYLAND SOFTWARE, INC.
    • SIEMENS HEALTHCARE LIMITED
    • BRIDGEHEAD SOFTWARE LTD.
    • CANOPY PARTNERS
    • CRELIOHEALTH INC.
    • ASPYRA, LLC
    • POSTDICOM
    • MEDICASOFT
    • ESAOTE SPA
    • VISUS HEALTH IT GMBH
  • 其他公司
    • ADVAHEALTH SOLUTIONS
    • SOFTTEAM SOLUTIONS PVT. LTD.
    • ARO SYSTEMS
    • CENTRAL DATA NETWORKS
    • ONEPACS
    • DEDALUS SPA.

第18章：調查方法

第19章附錄

Product Code: HIT 2128

The VNA & PACS market is projected to reach USD 8.57 billion by 2031 from USD 5.60 billion in 2026, at a CAGR of 8.9%. The VNA & PACS market is seeing an increase in demand due to the evolution in the delivery of healthcare services, in which providers need imaging platforms that help coordinate care in hospitals, clinics, and diagnostic facilities. The adoption of a data-centric healthcare model has increased the demand for imaging records, which would allow clinicians to gain access to patients' medical history and help with diagnosis and treatment plans.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsProduct Type, Modality, Deployment, Vendor Type, Application, End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

In addition to this, there is a demand for outpatient imaging centers, which need cloud-based PACS and VNA systems to support their imaging processes. Also, the rise in the adoption of software as a service (SaaS) business models by vendors has influenced the strategies of providers who look for flexible options and less expensive total cost of ownership models. This demand is further supported by the recent mergers and acquisitions in the industry, such as Intelerad Medical Systems Incorporated (Canada) acquired by GE HealthCare (US) in March 2026.

Vendor Neutral Archive (VNA) & PACS Market - IMG1

"By product type, the VNA segment accounted for the largest share of the VNA & PACS market in 2025."

By type of product, the VNA category will dominate the VNA & PACS market in 2025 since it provides healthcare institutions with the ability to centrally manage imaging data and ensure the sustainability of their IT infrastructure through interoperability among different systems. Through VNAs, healthcare providers can separate their data from their proprietary PACS and allow for easy information exchange without compromising system dependency issues. As stated by the Healthcare Information and Management Systems Society (2023), health facilities are shifting towards an enterprise imaging approach that stresses interoperable and vendor-neutral infrastructure to promote better patient care and improve the accessibility of their information. Similarly, according to the European Society of Radiology, long-term archiving of images and cross-enterprise data exchange have become fundamental in radiology practices today. Recent industry trends indicate that Hyland Software, Inc. (US) is developing its cloud-based VNA solution in 2025 to meet the demands of large-scale enterprises.

"By vendor type, the third-party vendor segment is expected to have the fastest growth during the forecast period."

Based on vendor type, the VNA & PACS market is segmented into independent vendors and third-party vendors. The third-party vendor market is projected to experience the highest rate of growth during the forecasted period, mainly owing to the growing demand for interoperability among different healthcare IT environments. Third-party vendors are involved in offering solutions that ensure interoperability among PACS, VNA, EHR, and various other clinical software applications so that healthcare organizations are able to integrate all of their data while maintaining their current infrastructure. As stated in a study conducted by Radsource in January 2025, PACS interoperability helps healthcare institutions become more efficient in the workflow process and improve overall patient care by exchanging data with other health systems. A recent development that shows the importance of PACS interoperability involves the enhancement of interoperable data management solutions by BridgeHead Software Ltd. (UK) and PaxeraHealth Corp. (US).

"APAC will witness the highest growth rate during the forecast period."

The VNA & PACS Market in the Asia Pacific region is witnessing robust growth due to increased spending on healthcare infrastructure, swift digitization of hospitals, and the escalating need for imaging diagnostics in a large number of patients. The governments in the region are aggressively implementing digital health strategies at the national level to facilitate better data exchange and accessibility. As per the report published by the World Health Organization (2021), nations in the Asia Pacific region are fast-tracking their digital health technology adoption to optimize the efficiency and delivery of services in health systems. Furthermore, the development of hospital chains and increased usage of electronic medical records are driving a high demand for comprehensive imaging data management systems. For example, FUJIFILM Holdings Corporation (Japan) is expanding its enterprise imaging solutions in Asia Pacific in 2025, whereas Canon Medical Systems Corporation (Japan) upgraded its imaging informatics offerings in 2025.

The breakdown of primary participants is as given below:

  • By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
  • By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
  • By Region - North America: 35%, Europe: 30%, Asia Pacific: 25%, Latin America: 6%, Middle East & Africa: 5%

Agfa-Gevaert Group (Belgium) and Canon Medical Systems Corporation (Japan) are some of the key players in the VNA PACS market.

  • The study includes an in-depth competitive analysis of these key players in the VNA PACS market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the VNA & PACS Market by Product Type (VNA [Department VNA, Multi-Department VNA, Multi-Site VNA], PACS [Department PACS, Multi-Department PACS, Multi-Site PACS]) | VNA & PACS Market, by Modality (CT, Mammography, MRI, Ultrasound, X-Rays, PET) | VNA & PACS Market, by Deployment (On-Premise Deployment, Cloud-Based Deployment, Hybrid Deployment) | VNA & PACS Market, by Vendor Type (Independent Vendor, Third-Party Vendor) | VNA & PACS Market, by Application (Cardiology, Orthopedic, Oncology, Neurology, Obstetrics and Gynecology, Other Applications) | VNA & PACS Market, by End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Other End Users) and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the VNA PACS market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; contracts, partnerships, agreements, new product & service launches, mergers & acquisitions, and recent developments associated with the VNA PACS market. Competitive analysis of upcoming startups in the VNA PACS market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the VNA & PACS market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

  • Analysis of key drivers (Heightened investments in medical imaging technologies, Growing demand for streamlined healthcare data management solutions, Integration of PACS/VNA with electronic medical records) restraints (High initial investment for implementing VNA and PACS solutions, Lack of standardized protocols and interoperability frameworks) opportunities (InFavorable government initiatives for better penetration of AI in medical imaging, Increasing medical imaging procedures and large imaging data silos, Rapid uptake of big data in healthcare) challenges (Rising security concerns related to cloud-based image processing and analytics, Data security issues in healthcare settings) influencing the growth of the VNA PACS market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the VNA & PACS Market
  • Market Development: Comprehensive information about lucrative markets; the report analyses the VNA PACS market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the VNA & PACS Market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like FUJIFILM Holdings Corporation (Japan), GE HealthCare (US), Merative (US), Sectra AB (Sweden), Siemens Healthineers AG (Germany), BridgeHead Software Ltd. (UK), among others, in the VNA PACS market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING VNA & PACS MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • 3.2 NORTH AMERICA VNA PACS MARKET, BY END USER AND COUNTRY
  • 3.3 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Heightened investments in medical imaging technologies
      • 4.2.1.2 Growing demand for streamlined healthcare data management solutions
      • 4.2.1.3 Integration of PACS/VNA with Electronic Medical Records (EMRs)
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High initial investment
      • 4.2.2.2 Lack of standardized protocols and interoperability frameworks
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Government initiatives to increase penetration of AI in medical imaging
      • 4.2.3.2 Increasing medical imaging procedures and large imaging data silos
      • 4.2.3.3 Rapid uptake of big data in healthcare
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Rising security concerns related to cloud-based image processing and analytics
      • 4.2.4.2 Data security issues
  • 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 THREAT OF NEW ENTRANTS
    • 5.1.5 THREAT OF SUBSTITUTES
  • 5.2 MACROECONOMICS INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM MAPPING
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE (ASP) TREND OF VNA AND PACS SOLUTIONS, BY PRODUCT TYPE
    • 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.6 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 CASE STUDY ANALYSIS
    • 5.9.1 AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL WORLDWIDE GROWTH OF ITS MEDICAL IMAGING PLATFORM
    • 5.9.2 NHS TRUST ADOPTED INTEGRATION AND INSTANT DATA ACCESS OFFERED BY SYNAPPS VNA TO ESTABLISH UNIFIED PLATFORM FOR STORING AND MANAGING DICOM IMAGE DATA
  • 5.10 IMPACT OF 2025 US TARIFF OVERVIEW
    • 5.10.1 INTRODUCTION
    • 5.10.2 KEY TARIFF RATES
    • 5.10.3 PRICE IMPACT ANALYSIS
  • 5.11 IMPACT ON COUNTRY/REGION
    • 5.11.1 THE US
    • 5.11.2 EUROPE
    • 5.11.3 APAC
  • 5.12 IMPACT ON END USE INDUSTRIES
  • 5.13 CONCLUSION

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 DICOM (DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE)
    • 6.1.2 ENTERPRISE IMAGING SOLUTIONS
    • 6.1.3 CLOUD-BASED STORAGE AND SERVICES
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 IMAGE EXCHANGE NETWORKS
    • 6.2.2 DATA ANALYTICS AND BUSINESS INTELLIGENCE
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 HEALTH INFORMATION EXCHANGE (HIE)
  • 6.4 PATENT ANALYSIS
    • 6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 6.5 FUTURE APPLICATIONS
    • 6.5.1 AI-ENABLED ENTERPRISE DIAGNOSTIC ORCHESTRATION
    • 6.5.2 MULTI-SPECIALTY ENTERPRISE IMAGING REPOSITORY
    • 6.5.3 IMAGING DATA LAKE FOR CLINICAL RESEARCH AND REAL-WORLD EVIDENCE
    • 6.5.4 CLOUD-BASED REGIONAL IMAGE EXCHANGE AND VIRTUAL CARE NETWORKS
    • 6.5.5 PERSONALIZED AND LONGITUDINAL IMAGING INTELLIGENCE

7 REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 REGULATIONS
      • 7.1.2.1 US
      • 7.1.2.2 Europe
      • 7.1.2.3 China
      • 7.1.2.4 Japan
      • 7.1.2.5 India
    • 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 INTRODUCTION
  • 8.2 DECISION-MAKING PROCESS
  • 8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.3.2 BUYING CRITERIA
  • 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
    • 8.5.1 UNMET NEEDS
    • 8.5.2 END-USER EXPECTATIONS
  • 8.6 MARKET PROFITABILITY

9 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE

  • 9.1 INTRODUCTION
  • 9.2 VNA
    • 9.2.1 DEPARTMENT VNA
      • 9.2.1.1 Phased imaging modernization driving VNA adoption and interoperability growth
    • 9.2.2 MULTI-DEPARTMENT VNA
      • 9.2.2.1 Cross-department imaging consolidation driving scalable enterprise data platform adoption
    • 9.2.3 MULTI-SITE VNA
      • 9.2.3.1 Cloud-based multi-site imaging consolidation enabling scalable, centralized care delivery
  • 9.3 PACS
    • 9.3.1 DEPARTMENT PACS
      • 9.3.1.1 Rising imaging volumes and workforce shortages driving workflow-centric PACS adoption
    • 9.3.2 MULTI-DEPARTMENT PACS
      • 9.3.2.1 Shared imaging platforms reducing silos and enabling cross-specialty collaboration
    • 9.3.3 MULTI-SITE PACS
      • 9.3.3.1 Centralized cloud PACS enabling cross-site workload balancing and productivity gains

10 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY

  • 10.1 INTRODUCTION
  • 10.2 CT
    • 10.2.1 RAPID RISE IN NEED FOR CT EXAMINATIONS TO SUPPORT MARKET GROWTH
  • 10.3 MAMMOGRAPHY
    • 10.3.1 RISE IN NUMBER OF MAMMOGRAPHY PROCEDURES TO DRIVE MARKET GROWTH
  • 10.4 ULTRASOUND
    • 10.4.1 RISING TECHNOLOGICAL ADVANCEMENT IN ULTRASOUND DEVICES TO SUPPORT MARKET GROWTH
  • 10.5 MAGNETIC RESONANCE IMAGING (MRI)
    • 10.5.1 MRI IS COST-EFFECTIVE AND EASILY AVAILABLE COMPARED TO PET
  • 10.6 X-RAY
    • 10.6.1 RAPID ADOPTION OF X-RAY IMAGING COMPARED TO OTHER MODALITIES TO BOOST MARKET
  • 10.7 PET
    • 10.7.1 INCREASING USE OF NUCLEAR MEDICINES TO SUPPORT POPULARITY OF PET

11 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL

  • 11.1 INTRODUCTION
  • 11.2 ON-PREMISE MODEL
    • 11.2.1 ON-PREMISE DEPLOYMENT MODEL PROVIDES HEALTHCARE ORGANIZATIONS WITH GREAT CONTROL AND SECURITY OVER SENSITIVE PATIENT DATA
  • 11.3 CLOUD-BASED MODEL
    • 11.3.1 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE CLOUD-BASED MODEL'S POPULARITY
  • 11.4 HYBRID MODEL
    • 11.4.1 UNIFIED EFFICIENCY FOR OPTIMAL PERFORMANCE TO DRIVE HYBRID VNA AND PACS SOLUTIONS

12 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE

  • 12.1 INTRODUCTION
  • 12.2 INDEPENDENT VENDOR
    • 12.2.1 DOMINANCE OF INDEPENDENT VENDORS TO CAPTURE SIGNIFICANT MARKET SHARE
  • 12.3 THIRD-PARTY VENDOR
    • 12.3.1 NEED FOR INNOVATIVE SOLUTIONS TO FUEL SURGE IN THIRD-PARTY VENDORS' PRESENCE IN MARKET

13 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION

  • 13.1 INTRODUCTION
  • 13.2 CARDIOLOGY
    • 13.2.1 RISING CASES OF CARDIAC DISORDERS TO DRIVE MARKET
  • 13.3 ORTHOPEDIC
    • 13.3.1 GROWTH IN CASES OF ARTHRITIS TO SUPPORT MARKET GROWTH
  • 13.4 ONCOLOGY
    • 13.4.1 RISE IN NUMBER OF CANCER CASES TO DRIVE USE OF VNA AND PACS SOLUTIONS FOR ONCOLOGY
  • 13.5 NEUROLOGY
    • 13.5.1 INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES TO SPUR GROWTH
  • 13.6 OBSTETRICS & GYNECOLOGY
    • 13.6.1 USE OF 3D AND 4D IMAGING FOR MONITORING FETUS GROWTH AND DIAGNOSING HIGH-RISK PREGNANCIES TO DRIVE APPLICATION OF VNA AND PACS SOLUTIONS
  • 13.7 OTHER APPLICATIONS

14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER

  • 14.1 INTRODUCTION
  • 14.2 HOSPITALS & CLINICS
    • 14.2.1 GROWING NEED TO IMPROVE PROFITABILITY OF HEALTHCARE SERVICES TO DRIVE USE OF HCIT IN HOSPITALS
  • 14.3 DIAGNOSTIC CENTERS
    • 14.3.1 POPULARITY OF DIAGNOSTIC CENTERS TO PROPEL USE OF VNA AND PACS SOLUTIONS
  • 14.4 AMBULATORY SURGERY CENTERS
    • 14.4.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT USE OF VNA AND PACS SOLUTIONS IN AMBULATORY SURGERY CENTERS
  • 14.5 OTHER END USERS

15 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION

  • 15.1 INTRODUCTION
  • 15.2 NORTH AMERICA
    • 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 15.2.2 US
      • 15.2.2.1 Regulatory Interoperability Mandates and Cloud-First Enterprise Imaging Strategies
    • 15.2.3 CANADA
      • 15.2.3.1 Pan-Canadian Interoperability Drive Opens Enterprise Imaging Investment Pipeline
  • 15.3 EUROPE
    • 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 15.3.2 GERMANY
      • 15.3.2.1 Hospital Future Act Investment Cycle Accelerates PACS and VNA Modernization
    • 15.3.3 UK
      • 15.3.3.1 NHS Digital Diagnostic Programme and AI Mandate Catalyze GBP 700M Imaging IT Overhaul
    • 15.3.4 FRANCE
      • 15.3.4.1 Segur du Numerique Imaging Wave Drives RIS-PACS Interoperability at National Scale
    • 15.3.5 ITALY
      • 15.3.5.1 PNRR-Funded Hospital Modernization Drives PACS Replacement and Digital Imaging Upgrades
    • 15.3.6 SPAIN
      • 15.3.6.1 National Health System Digitization and Regional Imaging Network Expansion Drive Market Growth
    • 15.3.7 REST OF EUROPE
  • 15.4 ASIA PACIFIC
    • 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 15.4.2 JAPAN
      • 15.4.2.1 Aging Society and Society 5.0 Strategy Drive Next-Generation PACS Replacement Cycle
    • 15.4.3 CHINA
      • 15.4.3.1 Healthy China 2030 and 14th Five-Year Plan Drive National EMR and Imaging Informatization
    • 15.4.4 INDIA
      • 15.4.4.1 Ayushman Bharat Digital Mission Creates National Imaging Data Infrastructure Demand
    • 15.4.5 REST OF ASIA PACIFIC
  • 15.5 LATIN AMERICA
    • 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 15.5.2 BRAZIL
      • 15.5.2.1 SUS Hospital Modernization and Private Sector AI Imaging Adoption Drive Regional Market Leadership
    • 15.5.3 MEXICO
      • 15.5.3.1 Private Hospital Expansion and Public Sector Technology Modernization Open PACS Growth Pathway
    • 15.5.4 REST OF LATIN AMERICA
  • 15.6 MIDDLE EAST & AFRICA
    • 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 15.6.2 GCC COUNTRIES
      • 15.6.2.1 Vision 2030 and National Health Digitization Investments Accelerate Smart Hospital Imaging Deployments
    • 15.6.3 REST OF MIDDLE EAST & AFRICA

16 COMPETITIVE LANDSCAPE

  • 16.1 OVERVIEW
  • 16.2 KEY PLAYERS' STRATEGIES/RIGHT TO WIN
    • 16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • 16.3 REVENUE SHARE ANALYSIS
  • 16.4 MARKET SHARE ANALYSIS, 2025
  • 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 16.5.1 STARS
    • 16.5.2 EMERGING LEADERS
    • 16.5.3 PERVASIVE PLAYERS
    • 16.5.4 PARTICIPANTS
    • 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 16.5.5.1 Company footprint
      • 16.5.5.2 Product footprint
      • 16.5.5.3 Deployment footprint
      • 16.5.5.4 End user footprint
      • 16.5.5.5 Regional footprint
  • 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 16.6.1 PROGRESSIVE COMPANIES
    • 16.6.2 RESPONSIVE COMPANIES
    • 16.6.3 DYNAMIC COMPANIES
    • 16.6.4 STARTING BLOCKS
    • 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 16.6.5.1 Detailed list of key startups/SMEs
  • 16.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 16.8 BRAND/SOFTWARE COMPARISON
  • 16.9 COMPETITIVE SCENARIO
    • 16.9.1 PRODUCT LAUNCHES & UPGRADES
    • 16.9.2 DEALS
    • 16.9.3 OTHER DEVELOPMENTS

17 COMPANY PROFILES

  • 17.1 KEY COMPANIES
    • 17.1.1 AGFA-GEVAERT GROUP
      • 17.1.1.1 Business overview
      • 17.1.1.2 Solutions offered
      • 17.1.1.3 Recent developments
        • 17.1.1.3.1 Deals
      • 17.1.1.4 MnM view
        • 17.1.1.4.1 Right to win
        • 17.1.1.4.2 Strategic choices
        • 17.1.1.4.3 Weaknesses & competitive threats
    • 17.1.2 FUJIFILM HOLDINGS CORPORATION
      • 17.1.2.1 Business overview
      • 17.1.2.2 Solutions offered
      • 17.1.2.3 Recent developments
        • 17.1.2.3.1 Deals
        • 17.1.2.3.2 Other developments
      • 17.1.2.4 MnM view
        • 17.1.2.4.1 Right to win
        • 17.1.2.4.2 Strategic choices
        • 17.1.2.4.3 Weaknesses & competitive threats
    • 17.1.3 SECTRA AB
      • 17.1.3.1 Business overview
      • 17.1.3.2 Solutions offered
      • 17.1.3.3 MnM view
        • 17.1.3.3.1 Right to win
        • 17.1.3.3.2 Strategic choices
        • 17.1.3.3.3 Weaknesses & competitive threats
    • 17.1.4 GE HEALTHCARE
      • 17.1.4.1 Business overview
      • 17.1.4.2 Solutions offered
      • 17.1.4.3 Recent developments
        • 17.1.4.3.1 Product launches
        • 17.1.4.3.2 Deals
      • 17.1.4.4 MnM view
        • 17.1.4.4.1 Right to win
        • 17.1.4.4.2 Strategic choices
        • 17.1.4.4.3 Weaknesses & competitive threats
    • 17.1.5 MERATIVE
      • 17.1.5.1 Business overview
      • 17.1.5.2 Solutions offered
      • 17.1.5.3 Recent developments
        • 17.1.5.3.1 Deals
      • 17.1.5.4 MnM view
        • 17.1.5.4.1 Key strengths
        • 17.1.5.4.2 Strategic choices
        • 17.1.5.4.3 Weaknesses & competitive threats
    • 17.1.6 KONINKLIJKE PHILIPS N.V.
      • 17.1.6.1 Business overview
      • 17.1.6.2 Solutions offered
      • 17.1.6.3 Recent developments
        • 17.1.6.3.1 Product launches
        • 17.1.6.3.2 Deals
    • 17.1.7 CANON MEDICAL SYSTEMS CORPORATION
      • 17.1.7.1 Business overview
      • 17.1.7.2 Solutions offered
      • 17.1.7.3 Recent developments
        • 17.1.7.3.1 Deals
    • 17.1.8 PAXERAHEALTH
      • 17.1.8.1 Business overview
      • 17.1.8.2 Solutions offered
    • 17.1.9 NOVARAD CORPORATION
      • 17.1.9.1 Business overview
      • 17.1.9.2 Solutions offered
    • 17.1.10 HYLAND SOFTWARE, INC.
      • 17.1.10.1 Business overview
      • 17.1.10.2 Solutions offered
      • 17.1.10.3 Recent developments
        • 17.1.10.3.1 Deals
    • 17.1.11 SIEMENS HEALTHCARE LIMITED
      • 17.1.11.1 Business overview
      • 17.1.11.2 Solutions offered
      • 17.1.11.3 Recent developments
        • 17.1.11.3.1 Deals
    • 17.1.12 BRIDGEHEAD SOFTWARE LTD.
      • 17.1.12.1 Business overview
      • 17.1.12.2 Solutions offered
    • 17.1.13 CANOPY PARTNERS
      • 17.1.13.1 Business overview
      • 17.1.13.2 Solutions offered
    • 17.1.14 CRELIOHEALTH INC.
      • 17.1.14.1 Business overview
      • 17.1.14.2 Solutions offered
    • 17.1.15 ASPYRA, LLC
      • 17.1.15.1 Business overview
      • 17.1.15.2 Solutions offered
    • 17.1.16 POSTDICOM
      • 17.1.16.1 Business overview
      • 17.1.16.2 Solutions offered
    • 17.1.17 MEDICASOFT
      • 17.1.17.1 Business overview
      • 17.1.17.2 Solutions offered
    • 17.1.18 ESAOTE SPA
      • 17.1.18.1 Business overview
      • 17.1.18.2 Solutions offered
      • 17.1.18.3 Recent developments
        • 17.1.18.3.1 Product launches
    • 17.1.19 VISUS HEALTH IT GMBH
      • 17.1.19.1 Business overview
      • 17.1.19.2 Solutions offered
  • 17.2 OTHER PLAYERS
    • 17.2.1 ADVAHEALTH SOLUTIONS
    • 17.2.2 SOFTTEAM SOLUTIONS PVT. LTD.
    • 17.2.3 ARO SYSTEMS
    • 17.2.4 CENTRAL DATA NETWORKS
    • 17.2.5 ONEPACS
    • 17.2.6 DEDALUS SPA.

18 RESEARCH METHODOLOGY

  • 18.1 RESEARCH APPROACH
    • 18.1.1 SECONDARY RESEARCH
      • 18.1.1.1 Key data from secondary sources
    • 18.1.2 PRIMARY RESEARCH
      • 18.1.2.1 Primary sources
      • 18.1.2.2 Key data from primary sources
      • 18.1.2.3 Breakdown of primary interviews
      • 18.1.2.4 Insights from primary experts
  • 18.2 RESEARCH METHODOLOGY DESIGN
  • 18.3 MARKET SIZE ESTIMATION
  • 18.4 DATA TRIANGULATION
  • 18.5 RESEARCH ASSUMPTIONS
  • 18.6 RESEARCH LIMITATIONS
    • 18.6.1 METHODOLOGY-RELATED
    • 18.6.2 SCOPE-RELATED
  • 18.7 RISK ASSESSMENT

19 APPENDIX

  • 19.1 DISCUSSION GUIDE
  • 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 19.3 CUSTOMIZATION OPTIONS
  • 19.4 RELATED REPORTS
  • 19.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 2 IMPACT OF PORTER'S FIVE FORCES ON VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • TABLE 3 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: ROLE IN ECOSYSTEM
  • TABLE 4 AVERAGE SELLING PRICE OF PACS SOLUTIONS, BY PRODUCT TYPE (USD)
  • TABLE 5 AVERAGE SELLING PRICE OF VNA SOLUTIONS, BY PRODUCT TYPE (USD)
  • TABLE 6 KEY CONFERENCES AND EVENTS, 2026-2027
  • TABLE 7 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN TELEHEALTH & TELEMEDICINE
  • TABLE 8 LIST OF PATENTS/PATENT APPLICATIONS, 2015-2025
  • TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF FOUR END USERS
  • TABLE 14 KEY BUYING CRITERIA FOR FOUR END USERS
  • TABLE 15 UNMET NEEDS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • TABLE 16 END-USER EXPECTATIONS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • TABLE 17 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 18 VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 19 VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 20 DEPARTMENT VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 21 MULTI-DEPARTMENT VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 22 MULTI-SITE VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 23 PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 24 PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 25 DEPARTMENT PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 26 MULTI-DEPARTMENT PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 27 MULTI-SITE PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 28 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 29 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR CT, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 30 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR MAMMOGRAPHY, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 31 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR ULTRASOUND, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 32 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 33 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR X-RAY, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 34 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR PET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 35 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 36 ON-PREMISE VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 37 CLOUD-BASED VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 38 HYBRID VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 39 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 40 INDEPENDENT VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 41 THIRD-PARTY VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 42 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 43 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR CARDIOLOGY APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 44 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 45 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR ONCOLOGY APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 46 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 47 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR OBSTETRICS AND GYNECOLOGY APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 48 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 49 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 50 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 51 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 52 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 53 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 54 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 55 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 56 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 57 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 58 NORTH AMERICA: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 59 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 60 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 61 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 62 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 63 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 64 US: KEY MACRO INDICATORS
  • TABLE 65 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 66 US: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 67 US: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 68 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 69 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 70 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 71 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 72 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 73 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 74 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 75 CANADA: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 76 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 77 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 78 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 79 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 80 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 81 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 82 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 83 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 84 EUROPE: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 85 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 86 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 87 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 88 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 89 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 90 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 91 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 92 GERMANY: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 93 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 94 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 95 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 96 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 97 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 98 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 99 UK: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 100 UK: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 101 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 102 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 103 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 104 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 105 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 106 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 107 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 108 FRANCE: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 109 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 110 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 111 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 112 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 113 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 114 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 115 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 116 ITALY: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 117 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 118 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 119 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 120 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 121 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 122 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 123 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 124 SPAIN: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 125 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 126 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 127 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 128 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 129 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 130 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 131 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 132 REST OF EUROPE: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 133 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 134 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 135 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 136 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 137 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 147 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 148 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 149 JAPAN: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 150 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 151 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 152 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 153 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 154 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 155 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 156 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 157 CHINA: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 158 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 159 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 160 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 161 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 162 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 163 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 164 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 165 INDIA: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 166 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 167 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 168 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 169 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 170 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 171 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 172 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 173 REST OF ASIA PACIFIC: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 174 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 175 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 176 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 177 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 178 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 179 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 180 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 181 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 182 LATIN AMERICA: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 183 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 184 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 185 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 186 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 187 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 188 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 189 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 190 BRAZIL: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 191 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 192 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 193 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 194 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 195 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 196 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 197 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 198 MEXICO: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 199 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 200 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 201 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 202 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 203 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 204 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 205 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 206 REST OF LATIN AMERICA: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 207 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 208 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 209 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 210 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 212 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
  • TABLE 213 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 221 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 229 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 231 REST OF MIDDLE EAST AND AFRICA: PACS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 232 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 233 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 234 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024-2031 (USD MILLION)
  • TABLE 235 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 236 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 237 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, JANUARY 2023-APRIL 2026
  • TABLE 238 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEGREE OF COMPETITION
  • TABLE 239 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: PRODUCT FOOTPRINT, 2025
  • TABLE 240 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEPLOYMENT FOOTPRINT, 2025
  • TABLE 241 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: END USER FOOTPRINT, 2025
  • TABLE 242 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: REGIONAL FOOTPRINT, 2025
  • TABLE 243 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025
  • TABLE 244 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025
  • TABLE 245 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-APRIL 2026
  • TABLE 246 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 247 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
  • TABLE 248 AGFA-GEVAERT GROUP: BUSINESS OVERVIEW
  • TABLE 249 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED
  • TABLE 250 AGFA-GEVAERT GROUP: DEALS
  • TABLE 251 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 252 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED
  • TABLE 253 FUJIFILM HOLDINGS CORPORATION: DEALS
  • TABLE 254 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS
  • TABLE 255 SECTRA AB: BUSINESS OVERVIEW
  • TABLE 256 SECTRA AB: SOLUTIONS OFFERED
  • TABLE 257 GE HEALTHCARE: BUSINESS OVERVIEW
  • TABLE 258 GE HEALTHCARE: SOLUTIONS OFFERED
  • TABLE 259 GE HEALTHCARE: PRODUCTS LAUNCHES
  • TABLE 260 GE HEALTHCARE: DEALS
  • TABLE 261 MERATIVE: BUSINESS OVERVIEW
  • TABLE 262 MERATIVE: SOLUTIONS OFFERED
  • TABLE 263 MERATIVE: DEALS
  • TABLE 264 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
  • TABLE 265 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED
  • TABLE 266 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
  • TABLE 267 KONINKLIJKE PHILIPS N.V.: DEALS
  • TABLE 268 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 269 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED
  • TABLE 270 CANON MEDICAL SYSTEMS CORPORATION: DEALS
  • TABLE 271 PAXERAHEALTH: BUSINESS OVERVIEW
  • TABLE 272 PAXERAHEALTH: SOLUTIONS OFFERED
  • TABLE 273 NOVARAD CORPORATION: BUSINESS OVERVIEW
  • TABLE 274 NOVARAD CORPORATION: SOLUTIONS OFFERED
  • TABLE 275 HYLAND SOFTWARE, INC.: BUSINESS OVERVIEW
  • TABLE 276 HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED
  • TABLE 277 HYLAND SOFTWARE, INC.: DEALS
  • TABLE 278 SIEMENS HEALTHCARE LIMITED: BUSINESS OVERVIEW
  • TABLE 279 SIEMENS HEALTHCARE LIMITED: SOLUTIONS OFFERED
  • TABLE 280 SIEMENS HEALTHCARE LIMITED: DEALS
  • TABLE 281 BRIDGEHEAD SOFTWARE LTD.: BUSINESS OVERVIEW
  • TABLE 282 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED
  • TABLE 283 CANOPY PARTNERS: BUSINESS OVERVIEW
  • TABLE 284 CANOPY PARTNERS: SOLUTIONS OFFERED
  • TABLE 285 CRELIOHEALTH INC.: BUSINESS OVERVIEW
  • TABLE 286 CRELIOHEALTH INC.: SOLUTIONS OFFERED
  • TABLE 287 ASPYRA, LLC: BUSINESS OVERVIEW
  • TABLE 288 ASPYRA, LLC: SOLUTIONS OFFERED
  • TABLE 289 POSTDICOM: BUSINESS OVERVIEW
  • TABLE 290 POSTDICOM: SOLUTIONS OFFERED
  • TABLE 291 MEDICASOFT: BUSINESS OVERVIEW
  • TABLE 292 MEDICASOFT: SOLUTIONS OFFERED
  • TABLE 293 ESAOTE SPA.: BUSINESS OVERVIEW
  • TABLE 294 ESAOTE SPA: SOLUTIONS OFFERED
  • TABLE 295 ESAOTE SPA: PRODUCT LAUNCHES
  • TABLE 296 VISUS HEALTH IT GMBH: BUSINESS OVERVIEW
  • TABLE 297 VISUS HEALTH IT GMBH: SOLUTIONS OFFERED

List of Figures

  • FIGURE 1 STUDY YEARS CONSIDERED
  • FIGURE 2 MARKET SCENARIO
  • FIGURE 3 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, 2024-2031 USD MILLION)
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • FIGURE 7 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD
  • FIGURE 8 EXPANSION OF ENTERPRISE IMAGING & MULTI-SITE HEALTHCARE NETWORKS FUELING DEMAND IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • FIGURE 9 HOSPITALS & END USERS AND US ACCOUNTED FOR LARGEST RESPECTIVE SHARES IN 2025
  • FIGURE 10 INDIA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD
  • FIGURE 11 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 12 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 13 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: ECOSYSTEM MAPPING
  • FIGURE 15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 16 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: INVESTMENT AND FUNDING SCENARIO, 2022-2025 (USD MILLION)
  • FIGURE 17 JURISDICTION AND TOP APPLICANT ANALYSIS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, JANUARY 2022-MAY 2025
  • FIGURE 18 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VNA AND PACS, JANUARY 2015 TO MAY 2025
  • FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF FOUR END USERS
  • FIGURE 20 KEY BUYING CRITERIA FOR FOUR END USERS
  • FIGURE 21 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT
  • FIGURE 22 UK: COUNT OF DIAGNOSTIC IMAGING ACTIVITY ON NHS PATIENTS, JANUARY 2022-JANUARY 2023 (MILLION)
  • FIGURE 23 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT
  • FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, 2021-2025 (USD MILLION)
  • FIGURE 25 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: MARKET SHARE ANALYSIS (2025)
  • FIGURE 26 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 27 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY FOOTPRINT, 2025
  • FIGURE 28 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 29 EV/EBITDA OF KEY VENDORS, 2026
  • FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VNA AND PACS VENDORS, 2026
  • FIGURE 31 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 32 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT
  • FIGURE 33 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 34 SECTRA AB: COMPANY SNAPSHOT
  • FIGURE 35 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 36 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 37 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 38 SIEMENS HEALTHCARE LIMITED: COMPANY SNAPSHOT
  • FIGURE 39 RESEARCH DESIGN
  • FIGURE 40 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 41 BOTTOM-UP APPROACH
  • FIGURE 42 TOP-DOWN APPROACH
  • FIGURE 43 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 44 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 45 DATA TRIANGULATION